Key result
NLR peaks in STEMI at ~4.4 compared with NSTEMI and unstable angina.
Why the study?
Commonly used biomarker assessments for ACS severity often face financial and institutional limitations. The Neutrophil-Lymphocyte Ratio (NLR) is a simple inflammatory marker from standard blood tests that may serve as a substitute measure for evaluating ACS severity across STEMI, NSTEMI, and unstable angina pectoris.
Does the Neutrophil-to-Lymphocyte Ratio (NLR) vary across different severity categories of Acute Coronary Syndrome (STEMI, NSTEMI, and unstable angina pectoris)?
Cross-Sectional (n=51)
No
Does the Neutrophil-to-Lymphocyte Ratio (NLR) vary across different severity categories of Acute Coronary Syndrome (STEMI, NSTEMI, and unstable angina pectoris)?
Answers are grounded in this paper and cite their sources.
Neutrophil-to-Lymphocyte Ratio (NLR) increases significantly with the clinical severity of acute coronary syndrome (highest in STEMI, followed by NSTEMI, and lowest in unstable angina), making it a potential cost-effective marker for ACS severity in resource-limited settings.
Background: Acute Coronary Syndrome (ACS) significantly elevates the risk of illness and death associated with cardiovascular disease. Evaluating severity is crucial for establishing suitable management. Nevertheless, often employed biomarker assessments frequently encounter financial restrictions and limitations inside healthcare institutions. The Neutrophil-Lymphocyte Ratio (NLR) is an uncomplicated inflammatory marker that can be derived from standard blood examinations and may serve as a substitute measure for evaluating the severity of Acute Coronary Syndrome (ACS). Objective: This research seeks to identify the variations in NLR among individuals with ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI), and unstable angina pectoris (UAP) at Husada Utama Hospital Surabaya. Methods: The research employed an observational analytical cross-sectional design, encompassing 51 ACS patients categorized into three groups of 17 patients each, utilizing purposive sampling. Data analysis encompassed the Shapiro-Wilk normality assessment and the Kruskal-Wallis test due to the non-normal distribution of the data. Values were deemed significant if 𝜌<0.05. Results: This research demonstrated a statistically significant disparity in NLR among the three ACS categories (𝜌<0.001), with STEMI exhibiting the highest NLR (mean ± SD: 4.39 ± 1.68; median: 4.71 [range: 2.04 – 8.32]), followed by NSTEMI (mean ± SD: 2.72 ± 1.59; median: 2.17 [range:1.51 – 7.78]), and UAP presenting the lowest (mean ± SD: 2.07 ± 0.74; median: 1.87 [range: 1.45 – 4.64]). These results suggest that a rise in NLR correlates with the severity of ACS and signifies an elevated degree of systemic inflammation. Conclusion: The NLR serves as a straightforward, cost-effective, and valuable metric for evaluating the severity of ACS in healthcare settings with constrained resources
No takes yet. Share an insight, caveat, or question.
Kurningtyas et al. (2026) conducted a cross-sectional in Acute Coronary Syndrome (ACS) (n=51). Neutrophil-to-Lymphocyte Ratio (NLR) across STEMI and NSTEMI vs. Unstable angina pectoris (UAP) was evaluated on Neutrophil-to-Lymphocyte Ratio (NLR) variation across ACS categories (p=<0.001). Neutrophil-to-lymphocyte ratio differed across ACS subtypes, being highest in STEMI, followed by NSTEMI and unstable angina.
Synapse has enriched 10 related papers. Consider them for comparative context: